CW, P., PL, M., & HT, D. (2025). LncRNA ACTA2-AS1 Inhibits Tumorigenesis of Prostate Cancer by Maintaining ACTA2 Expression. The Tohoku journal of experimental medicine, 267(2), 203. https://doi.org/10.1620/tjem.2025.J042
Chicago Style (17th ed.) CitationCW, Peng, Ma PL, and Dai HT. "LncRNA ACTA2-AS1 Inhibits Tumorigenesis of Prostate Cancer by Maintaining ACTA2 Expression." The Tohoku Journal of Experimental Medicine 267, no. 2 (2025): 203. https://doi.org/10.1620/tjem.2025.J042.
MLA (9th ed.) CitationCW, Peng, et al. "LncRNA ACTA2-AS1 Inhibits Tumorigenesis of Prostate Cancer by Maintaining ACTA2 Expression." The Tohoku Journal of Experimental Medicine, vol. 267, no. 2, 2025, p. 203, https://doi.org/10.1620/tjem.2025.J042.
Warning: These citations may not always be 100% accurate.